Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




What Is the Effect of Delayed Radiation After Primary Breast Cancer Treatment?
Link ID 10114
Title What Is the Effect of Delayed Radiation After Primary Breast Cancer Treatment?
Url http://www.medscape.com/viewarticle/582479?src=rss
Description Women in developing nations many not have access to radiation facilities or may delay such treatment. Does radiation still have value in preventing disease recurrence when it is delayed?
Medscape Hematology-Oncology
Category Articles > Hematology-Oncology
Keywords
Date Oct 30, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. FDA Okays Everolimus for Rare Type of Pancreatic Cancer
  Everolimus (Afinitor) has been approved to treat patients with advanced pancreatic neuroendocrine tumors. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Neoadjuvant Aromatase Inhibitors Lower Mastectomy Rates
  The neoadjuvant use of aromatase inhibitors shrinks estrogen-receptor-positive breast tumors, permitting more breast-conserving surgery in postmenopausal women with stage II to III breast cancer. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Pathological Complete Response of Breast Tumors to Specific Chemotherapies Can Be Predicted
  A phase 3 clinical trial has confirmed the predictive validity of gene-expression signatures and drug responses established in vitro. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Jury Still Out on Genotyping Before Prescribing Tamoxifen
  Although a survey of British oncologists showed a mixed response to testing before prescribing tamoxifen, most agreed that drugs that might interact should be avoided. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Adjuvant Therapy for HER2-Positive Breast Cancer: An Expert Interview With Dr. Harold Burstein
  What do clinicians need to know in 2008? Dr. Harold Burstein brings readers up to date about trastuzumab-based regimens, selecting a chemotherapy backbone, and monitoring cardiac function.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS